Defining, Evaluating, and Sharing Methodologies for Quality Control in Diagnostic Imaging
NCT05770024 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2024-03-25
Summary
The purpose of the study is to validate a radiological quality control (QC) system on the performance of diagnostic imaging. Patient images, previously anonymized by each radiologic diagnostic structures (SDR), will be sent to the QC service, which will blindly submit the images for evaluation external peer review by experts in the field. Through the blinded approach, the information obtained from the QC will allow the SDR to know its own performance analytics, but not those of other SDRs using the service, and to a centralized system to have an anonymized estimate of the quality of performance delivered. Finally, the analyzed data will provide not only a mere count, but will allow to reduce and prevent errors in the appropriateness, execution, reporting and diagnostic content of the examinations
Conditions
- Subjects Undergoing Diagnostic Imaging Tests
Interventions
- OTHER
-
imaging tests
X-ray radiography (RX); computer tomography (CT); magnetic resonance (MR); positron emission tomography (PET); single photon emission computed tomography (SPECT)
Sponsors & Collaborators
-
IRCCS SYNLAB SDN
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-09-03
- Primary Completion
- 2024-01-31
- Completion
- 2024-09-30
Countries
- Italy
Study Locations
More Related Trials
-
Validation of USPIO-enhanced MRI for Detection of Lymph Node Metastases in Head and Neck Carcinoma
NCT03817307 ·Status: UNKNOWN ·Phase: NA
-
Imaging Correlates of Renal Cell Carcinoma Biological Features
NCT01665703 ·Status: COMPLETED ·Phase: NA
-
Monitoring Response to Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast DCE-MRI
NCT05744518 ·Status: UNKNOWN
-
Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma
NCT06916624 ·Status: RECRUITING
-
Utility of Perfusion MRI to Detect Radiation Necrosis in Patients With Brain Metastases
NCT03680144 ·Status: COMPLETED ·Phase: NA
-
Monitoring of Breast Cancers Treated by Neoadjuvant Therapy Via Diffusion-weighted Magnetic Resonance Imaging
NCT02798484 ·Status: COMPLETED ·Phase: NA
-
Integrated PET/MR Imaging With Amino Acid Radiotracers in the Evaluation of Brain Neoplasms: Assessing Diagnostic Accuracy and Therapeutic Response
NCT07211360 ·Status: NOT_YET_RECRUITING
-
Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Neuroendocrin Tumors.
NCT06159920 ·Status: RECRUITING
-
89Zr-labeled NY009 PET Imaging in Patients
NCT05691855 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Comparaison Between MRI Alone or Combined With Positron Emission Tomography for Brain Metastasis Diagnosis
NCT05095766 ·Status: COMPLETED
-
The Reproducibility Of Diffusion Weighted Magnetic Resonance Imaging For Neuroendocrine Tumor Liver Metastases
NCT01423734 ·Status: COMPLETED
-
Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image Data
NCT06533709 ·Status: RECRUITING
-
Groin Sentinel Node Biopsy and 18FDG-PET/CT in cN0 Vulvar Cancer Patients Candidate to Standard Lymphadenectomy
NCT02969278 ·Status: UNKNOWN ·Phase: NA
-
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
NCT00019565 ·Status: COMPLETED ·Phase: PHASE1
-
MRI-based Clinico-radiomics Predicting Lymph Node Metastasis Status of Hilar Cholangiocarcinoma
NCT05626127 ·Status: UNKNOWN
-
MRI in Ovarian Tumors
NCT05769205 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma.
NCT05340569 ·Status: COMPLETED ·Phase: NA
-
MRI in Diagnosing Solid Tumors of the Eye and Orbit
NCT01653080 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Impact of Predicting Anti-angiogenic Response in mRCC Using Functional Imaging
NCT00842790 ·Status: COMPLETED
-
Dual Perfusion Imaging for Characterizing Vascular Architecture of Brain Lesions
NCT05358340 ·Status: UNKNOWN ·Phase: NA
-
Impact of Reconstruction Method (ASIR, FBP) Used in CT on Bone SPECT/CT Image Quality
NCT01800084 ·Status: COMPLETED ·Phase: NA
-
Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.
NCT00782691 ·Status: UNKNOWN
-
Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction
NCT05537675 ·Status: COMPLETED
-
Monitoring of Breast Cancers Treated by Neoadjuvant Radiotherapy Via Magnetic Resonance Imaging
NCT02916719 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Diagnostic and Prognostic Role of PET (PET/CT and PET/MRI) in Gynecological Tumors.
NCT06159907 ·Status: RECRUITING